Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
40.25
-0.72 (-1.76%)
Feb 21, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $245.46 million as of February 21, 2025. Its market cap has increased by 4,903.42% in one year.
Market Cap
245.46M
Enterprise Value
239.44M
1-Year Change
4,903.42%
Ranking
Category
Stock Price
$40.25
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $245.46M, a decrease of -11.11%. That is a compound annual growth rate of -2.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |